[1]
Du J, Wang T, Huang P, Cui S, Gao C, Lin Y, Fu R, Shen J, He Y, Tan Y, Chen S. Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy. Parkinsonism & related disorders. 2018 Dec:57():58-62. doi: 10.1016/j.parkreldis.2018.07.017. Epub 2018 Jul 26
[PubMed PMID: 30093363]
[2]
Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers. Nutritional neuroscience. 2019 Sep:22(9):607-615. doi: 10.1080/1028415X.2017.1421039. Epub 2018 Jan 3
[PubMed PMID: 29298622]
[3]
Cordero MD, Santos-García R, Bermejo-Jover D, Sánchez-Domínguez B, Jaramillo-Santos MR, Bullón P. Coenzyme Q10 in salivary cells correlate with blood cells in Fibromyalgia: improvement in clinical and biochemical parameter after oral treatment. Clinical biochemistry. 2012 Apr:45(6):509-11. doi: 10.1016/j.clinbiochem.2012.02.001. Epub 2012 Feb 10
[PubMed PMID: 22342824]
[4]
Jafari M, Mousavi SM, Asgharzadeh A, Yazdani N. Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews. Indian heart journal. 2018 Jul:70 Suppl 1(Suppl 1):S111-S117. doi: 10.1016/j.ihj.2018.01.031. Epub 2018 Jan 31
[PubMed PMID: 30122240]
Level 1 (high-level) evidence
[5]
Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, Fernández Vega A, de la Mata M, Delgado Pavón A, de Miguel M, Pérez Calero C, Villanueva Paz M, Cotán D, Sánchez-Alcázar JA. Coenzyme q10 therapy. Molecular syndromology. 2014 Jul:5(3-4):187-97. doi: 10.1159/000360101. Epub
[PubMed PMID: 25126052]
[6]
Yuruk Yildirim Z, Toksoy G, Uyguner O, Nayir A, Yavuz S, Altunoglu U, Turkkan ON, Sevinc B, Gokcay G, Kurkcu Gunes D, Kiyak A, Yilmaz A. Primary coenzyme Q10 Deficiency-6 (COQ10D6): Two siblings with variable expressivity of the renal phenotype. European journal of medical genetics. 2020 Jan:63(1):103621. doi: 10.1016/j.ejmg.2019.01.011. Epub 2019 Jan 22
[PubMed PMID: 30682496]
[7]
. Correction to: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Sep 27:146(13):e185. doi: 10.1161/CIR.0000000000001097. Epub 2022 Sep 26
[PubMed PMID: 36154623]
Level 1 (high-level) evidence
[8]
Bhatt KN, Butler J. Myocardial Energetics and Heart Failure: a Review of Recent Therapeutic Trials. Current heart failure reports. 2018 Jun:15(3):191-197. doi: 10.1007/s11897-018-0386-8. Epub
[PubMed PMID: 29707741]
[9]
Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP. Coenzyme Q10 and exercise training in chronic heart failure. European heart journal. 2006 Nov:27(22):2675-81
[PubMed PMID: 16882678]
[10]
Dai YL, Luk TH, Yiu KH, Wang M, Yip PM, Lee SW, Li SW, Tam S, Fong B, Lau CP, Siu CW, Tse HF. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis. 2011 Jun:216(2):395-401. doi: 10.1016/j.atherosclerosis.2011.02.013. Epub 2011 Feb 17
[PubMed PMID: 21388622]
Level 1 (high-level) evidence
[11]
Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem. Current cardiology reviews. 2018:14(3):164-174. doi: 10.2174/1573403X14666180416115428. Epub
[PubMed PMID: 29663894]
[12]
Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia. 2002 Mar:45(3):420-6
[PubMed PMID: 11914748]
[13]
Ayers J, Cook J, Koenig RA, Sisson EM, Dixon DL. Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: a Systematic Review. Current atherosclerosis reports. 2018 May 16:20(6):29. doi: 10.1007/s11883-018-0730-1. Epub 2018 May 16
[PubMed PMID: 29766349]
Level 1 (high-level) evidence
[14]
Alehagen U, Aaseth J, Alexander J, Johansson P. Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly. PloS one. 2018:13(4):e0193120. doi: 10.1371/journal.pone.0193120. Epub 2018 Apr 11
[PubMed PMID: 29641571]
Level 1 (high-level) evidence
[15]
Wong AP, Kassab YW, Mohamed AL, Abdul Qader AM. Review: Beyond conventional therapies: Complementary and alternative medicine in the management of hypertension: An evidence-based review. Pakistan journal of pharmaceutical sciences. 2018 Jan:31(1):237-244
[PubMed PMID: 29348109]
[16]
Cordero MD, Alcocer-Gómez E, de Miguel M, Culic O, Carrión AM, Alvarez-Suarez JM, Bullón P, Battino M, Fernández-Rodríguez A, Sánchez-Alcazar JA. Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Antioxidants & redox signaling. 2013 Oct 20:19(12):1356-61. doi: 10.1089/ars.2013.5260. Epub 2013 Apr 6
[PubMed PMID: 23458405]
[17]
Cordero MD, Alcocer-Gómez E, de Miguel M, Cano-García FJ, Luque CM, Fernández-Riejo P, Fernández AM, Sánchez-Alcazar JA. Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? case series with 5 patients. Mitochondrion. 2011 Jul:11(4):623-5. doi: 10.1016/j.mito.2011.03.122. Epub 2011 Apr 7
[PubMed PMID: 21496502]
Level 2 (mid-level) evidence
[18]
Glover EI, Martin J, Maher A, Thornhill RE, Moran GR, Tarnopolsky MA. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle & nerve. 2010 Nov:42(5):739-48. doi: 10.1002/mus.21758. Epub
[PubMed PMID: 20886510]
Level 1 (high-level) evidence
[19]
Safarinejad MR. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study. International journal of impotence research. 2010 Sep-Oct:22(5):298-309. doi: 10.1038/ijir.2010.20. Epub 2010 Aug 19
[PubMed PMID: 20720560]
Level 1 (high-level) evidence
[20]
Zaleski AL, Taylor BA, Thompson PD. Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but…. Advances in nutrition (Bethesda, Md.). 2018 Jul 1:9(4):519S-523S. doi: 10.1093/advances/nmy010. Epub
[PubMed PMID: 30032220]
Level 3 (low-level) evidence
[21]
Skarlovnik A, Janić M, Lunder M, Turk M, Šabovič M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Medical science monitor : international medical journal of experimental and clinical research. 2014 Nov 6:20():2183-8. doi: 10.12659/MSM.890777. Epub 2014 Nov 6
[PubMed PMID: 25375075]
Level 1 (high-level) evidence
[22]
Mizuno K, Tanaka M, Nozaki S, Mizuma H, Ataka S, Tahara T, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition (Burbank, Los Angeles County, Calif.). 2008 Apr:24(4):293-9. doi: 10.1016/j.nut.2007.12.007. Epub 2008 Feb 13
[PubMed PMID: 18272335]
[23]
Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, Segers A, Burdine D, Manning P, Kabbouche MA. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007 Jan:47(1):73-80
[PubMed PMID: 17355497]
[24]
Yaghini O, Hoseini N, Ghazavi MR, Mansouri V, Nasiri J, Moosavian T, Salehi MM. A Comparative Study on the Efficacy of Coenzyme Q10 and Amitriptyline in the Prophylactic Treatment of Migraine Headaches in Children: A Randomized Controlled Trial. Advanced biomedical research. 2022:11():43. doi: 10.4103/abr.abr_235_20. Epub 2022 May 30
[PubMed PMID: 35814300]
Level 2 (mid-level) evidence
[25]
Chase M, Cocchi MN, Liu X, Andersen LW, Holmberg MJ, Donnino MW. Coenzyme Q10 in acute influenza. Influenza and other respiratory viruses. 2019 Jan:13(1):64-70. doi: 10.1111/irv.12608. Epub 2018 Sep 30
[PubMed PMID: 30156030]
[26]
Barletta MA, Marino G, Spagnolo B, Bianchi FP, Falappone PCF, Spagnolo L, Gatti P. Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome. Clinical and experimental medicine. 2023 Jul:23(3):667-678. doi: 10.1007/s10238-022-00871-8. Epub 2022 Aug 22
[PubMed PMID: 35994177]
[27]
Mehrpooya M, Yasrebifar F, Haghighi M, Mohammadi Y, Jahangard L. Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression: A Double-Blind Controlled Clinical Trial. Journal of clinical psychopharmacology. 2018 Oct:38(5):460-466. doi: 10.1097/JCP.0000000000000938. Epub
[PubMed PMID: 30106880]
Level 1 (high-level) evidence
[28]
Izadi A, Ebrahimi S, Shirazi S, Taghizadeh S, Parizad M, Farzadi L, Gargari BP. Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism. 2019 Feb 1:104(2):319-327. doi: 10.1210/jc.2018-01221. Epub
[PubMed PMID: 30202998]
[29]
Schniertshauer D, Müller S, Mayr T, Sonntag T, Gebhard D, Bergemann J. Accelerated Regeneration of ATP Level after Irradiation in Human Skin Fibroblasts by Coenzyme Q10. Photochemistry and photobiology. 2016 May:92(3):488-94. doi: 10.1111/php.12583. Epub 2016 Apr 18
[PubMed PMID: 26946184]
[30]
Kędziora-Kornatowska K, Czuczejko J, Motyl J, Szewczyk-Golec K, Kozakiewicz M, Pawluk H, Kędziora J, Błaszczak R, Banach M, Rysz J. Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study. Archives of medical science : AMS. 2010 Aug 30:6(4):513-8. doi: 10.5114/aoms.2010.14461. Epub 2010 Sep 7
[PubMed PMID: 22371793]
Level 3 (low-level) evidence
[31]
Cordero MD, Cano-García FJ, Alcocer-Gómez E, De Miguel M, Sánchez-Alcázar JA. Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q₁₀ effect on clinical improvement. PloS one. 2012:7(4):e35677. doi: 10.1371/journal.pone.0035677. Epub 2012 Apr 19
[PubMed PMID: 22532869]
[32]
López-Lluch G, Del Pozo-Cruz J, Sánchez-Cuesta A, Cortés-Rodríguez AB, Navas P. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition (Burbank, Los Angeles County, Calif.). 2019 Jan:57():133-140. doi: 10.1016/j.nut.2018.05.020. Epub 2018 Jun 27
[PubMed PMID: 30153575]
[33]
Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free radical research. 2006 May:40(5):445-53
[PubMed PMID: 16551570]
[34]
Campisi L, La Motta C. The Use of the Coenzyme Q(10) as a Food Supplement in the Management of Fibromyalgia: A Critical Review. Antioxidants (Basel, Switzerland). 2022 Sep 30:11(10):. doi: 10.3390/antiox11101969. Epub 2022 Sep 30
[PubMed PMID: 36290691]
[35]
Knott A, Achterberg V, Smuda C, Mielke H, Sperling G, Dunckelmann K, Vogelsang A, Krüger A, Schwengler H, Behtash M, Kristof S, Diekmann H, Eisenberg T, Berroth A, Hildebrand J, Siegner R, Winnefeld M, Teuber F, Fey S, Möbius J, Retzer D, Burkhardt T, Lüttke J, Blatt T. Topical treatment with coenzyme Q10-containing formulas improves skin's Q10 level and provides antioxidative effects. BioFactors (Oxford, England). 2015 Nov-Dec:41(6):383-90. doi: 10.1002/biof.1239. Epub 2015 Dec 9
[PubMed PMID: 26648450]
[36]
Cluis CP, Burja AM, Martin VJ. Current prospects for the production of coenzyme Q10 in microbes. Trends in biotechnology. 2007 Nov:25(11):514-21
[PubMed PMID: 17935805]
[37]
Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2018 Oct 2:7(19):e009835. doi: 10.1161/JAHA.118.009835. Epub
[PubMed PMID: 30371340]
Level 1 (high-level) evidence
[38]
Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005 Feb 22:64(4):713-5
[PubMed PMID: 15728298]
Level 1 (high-level) evidence
[39]
Shoeibi A, Olfati N, Soltani Sabi M, Salehi M, Mali S, Akbari Oryani M. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial. Acta neurologica Belgica. 2017 Mar:117(1):103-109. doi: 10.1007/s13760-016-0697-z. Epub 2016 Sep 26
[PubMed PMID: 27670440]
[40]
Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, Salviati L, Trevisson E, Agosto C, Doimo M, Navas P. Primary Coenzyme Q(10) Deficiency Overview. GeneReviews(®). 1993:():
[PubMed PMID: 28125198]
Level 3 (low-level) evidence
[41]
Wang Y, Hekimi S. The efficacy of coenzyme Q(10) treatment in alleviating the symptoms of primary coenzyme Q(10) deficiency: A systematic review. Journal of cellular and molecular medicine. 2022 Sep:26(17):4635-4644. doi: 10.1111/jcmm.17488. Epub 2022 Aug 19
[PubMed PMID: 35985679]
Level 1 (high-level) evidence
[42]
KDIGO Conference Participants. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2022 Jun:101(6):1126-1141. doi: 10.1016/j.kint.2022.03.019. Epub 2022 Apr 20
[PubMed PMID: 35460632]
[43]
Florou P, Anagnostis P, Theocharis P, Chourdakis M, Goulis DG. Does coenzyme Q(10) supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials. Journal of assisted reproduction and genetics. 2020 Oct:37(10):2377-2387. doi: 10.1007/s10815-020-01906-3. Epub 2020 Aug 7
[PubMed PMID: 32767206]
Level 1 (high-level) evidence
[45]
Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators. Molecular aspects of medicine. 1994:15 Suppl():s287-94
[PubMed PMID: 7752841]
Level 2 (mid-level) evidence
[46]
PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Coenzyme Q10 (PDQ®): Health Professional Version. PDQ Cancer Information Summaries. 2002:():
[PubMed PMID: 26389329]
[47]
Feigin A, Kieburtz K, Como P, Hickey C, Claude K, Abwender D, Zimmerman C, Steinberg K, Shoulson I. Assessment of coenzyme Q10 tolerability in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society. 1996 May:11(3):321-3
[PubMed PMID: 8723151]
[48]
Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskrift for laeger. 1998 May 25:160(22):3226-7
[PubMed PMID: 9621803]
[49]
Engelsen J, Nielsen JD, Hansen KF. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskrift for laeger. 2003 Apr 28:165(18):1868-71
[PubMed PMID: 12772396]
Level 1 (high-level) evidence
[50]
Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial. Thrombosis and haemostasis. 2002 Jun:87(6):1075-6
[PubMed PMID: 12083489]
Level 1 (high-level) evidence
[51]
Ben Fredj N, Ben Fadhel N, Chaabane A, Chadly Z, Ben Romdhane H, Boughattas A, Aouam K. Colloidal silica-induced hypersensitivity: myth or reality. International journal of clinical pharmacy. 2016 Feb:38(1):7-9. doi: 10.1007/s11096-015-0225-x. Epub 2015 Nov 27
[PubMed PMID: 26613737]
[52]
Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K. Safety assessment of coenzyme Q10 (CoQ10). BioFactors (Oxford, England). 2008:32(1-4):199-208
[PubMed PMID: 19096117]
[53]
Nam DW, Park SS, Lee SM, Suh MW, Park MK, Song JJ, Choi BY, Lee JH, Oh SH, Moon KC, Ahn YH, Kang HG, Cheong HI, Kim JH, Lee SY. Effects of CoQ10 Replacement Therapy on the Audiological Characteristics of Pediatric Patients with COQ6 Variants. BioMed research international. 2022:2022():5250254. doi: 10.1155/2022/5250254. Epub 2022 Sep 9
[PubMed PMID: 36124066]
[54]
Deshmukh G, Venkataramaiah SB, Doreswamy CM, Umesh MC, Subbanna RB, Pradhan BK, Seekallu S, Sekar R, Prabhu K, Sadagopan S, Arumugam SN, Sharma S, Gavara G, Balaraman S, Sambasivam G, Chandrappa RK, Flynn S, Shivarudraiah P. Safety Assessment of Ubiquinol Acetate: Subchronic Toxicity and Genotoxicity Studies. Journal of toxicology. 2019:2019():3680757. doi: 10.1155/2019/3680757. Epub 2019 Apr 1
[PubMed PMID: 31057608]
[55]
Emmanuele V, López LC, Berardo A, Naini A, Tadesse S, Wen B, D'Agostino E, Solomon M, DiMauro S, Quinzii C, Hirano M. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Archives of neurology. 2012 Aug:69(8):978-83. doi: 10.1001/archneurol.2012.206. Epub
[PubMed PMID: 22490322]